Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 191

1.

Dopamine and impulse control disorders in Parkinson's disease.

Weintraub D.

Ann Neurol. 2008 Dec;64 Suppl 2:S93-100. doi: 10.1002/ana.21454.

2.

Impulse control and related disorders in Parkinson's disease.

Weintraub D, Nirenberg MJ.

Neurodegener Dis. 2013;11(2):63-71. doi: 10.1159/000341996. Epub 2012 Oct 3.

PMID:
23038208
3.

Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.

Weintraub D.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 3:S110-3. doi: 10.1016/S1353-8020(09)70794-1.

PMID:
20082968
4.

Clinical spectrum of impulse control disorders in Parkinson's disease.

Weintraub D, David AS, Evans AH, Grant JE, Stacy M.

Mov Disord. 2015 Feb;30(2):121-7. doi: 10.1002/mds.26016. Epub 2014 Nov 5. Review. Erratum in: Mov Disord. 2015 Jun;30(7):1010.

PMID:
25370355
5.

Impulse control disorders in Parkinson's disease.

Weintraub D, Potenza MN.

Curr Neurol Neurosci Rep. 2006 Jul;6(4):302-6. Review.

PMID:
16822350
6.

Impulse Control and Related Disorders in Parkinson's Disease.

Weintraub D, Claassen DO.

Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1.

PMID:
28802938
7.

Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.

Ceravolo R, Frosini D, Rossi C, Bonuccelli U.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S111-5. doi: 10.1016/S1353-8020(09)70847-8. Review.

PMID:
20123548
8.

[Impulsive-compulsive syndrome in Parkinson's disease].

Nikitina AV, Fedorova NV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):32-8. Russian.

PMID:
23994929
9.

Treatment of impulse control disorders in Parkinson's disease: Practical considerations and future directions.

Ramirez-Zamora A, Gee L, Boyd J, Biller J.

Expert Rev Neurother. 2016;16(4):389-99. doi: 10.1586/14737175.2016.1158103. Epub 2016 Mar 10. Review.

PMID:
26923084
10.

Spectrum of addictions in Parkinson's disease: from dopamine dysregulation syndrome to impulse control disorders.

Ceravolo R, Frosini D, Rossi C, Bonuccelli U.

J Neurol. 2010 Nov;257(Suppl 2):S276-83. doi: 10.1007/s00415-010-5715-0. Review.

PMID:
21080189
11.

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB.

Arch Neurol. 2006 Jul;63(7):969-73.

12.

Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.

Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, Mata M, Olmedilla Gonzalez N, Mahillo Fernandez I.

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. doi: 10.1136/jnnp-2013-306787. Epub 2014 Jan 16.

PMID:
24434037
13.

Dopamine dysregulation syndrome: an overview of its epidemiology, mechanisms and management.

O'Sullivan SS, Evans AH, Lees AJ.

CNS Drugs. 2009;23(2):157-70. doi: 10.2165/00023210-200923020-00005. Review.

PMID:
19173374
14.

[Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].

Sáez-Francàs N, Martí Andrés G, Ramírez N, de Fàbregues O, Álvarez-Sabín J, Casas M, Hernández-Vara J.

Neurologia. 2016 May;31(4):231-8. doi: 10.1016/j.nrl.2015.05.002. Epub 2015 Jun 19. Spanish.

15.

Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Voon V, Reynolds B, Brezing C, Gallea C, Skaljic M, Ekanayake V, Fernandez H, Potenza MN, Dolan RJ, Hallett M.

Psychopharmacology (Berl). 2010 Jan;207(4):645-59. doi: 10.1007/s00213-009-1697-y. Epub 2009 Oct 20.

16.

Clinical characteristics of impulse control and repetitive behavior disorders in Parkinson's disease.

Kim J, Kim M, Kwon DY, Seo WK, Kim JH, Baik JS, Koh SB.

J Neurol. 2013 Feb;260(2):429-37. doi: 10.1007/s00415-012-6645-9. Epub 2012 Aug 15.

PMID:
22893307
17.

Prospective cohort study of impulse control disorders in Parkinson's disease.

Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ.

Mov Disord. 2013 Mar;28(3):327-33. doi: 10.1002/mds.25291. Epub 2013 Jan 2.

18.
19.

A European multicentre survey of impulse control behaviours in Parkinson's disease patients treated with short- and long-acting dopamine agonists.

Rizos A, Sauerbier A, Antonini A, Weintraub D, Martinez-Martin P, Kessel B, Henriksen T, Falup-Pecurariu C, Silverdale M, Durner G, Røkenes Karlsen K, Grilo M, Odin P, Chaudhuri KR; EUROPAR and the IPMDS Non-Motor-PD-Study Group.

Eur J Neurol. 2016 Aug;23(8):1255-61. doi: 10.1111/ene.13034. Epub 2016 May 11.

PMID:
27170229
20.

Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.

Fantini ML, Macedo L, Zibetti M, Sarchioto M, Vidal T, Pereira B, Marques A, Debilly B, Derost P, Ulla M, Vitello N, Cicolin A, Lopiano L, Durif F.

J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):174-9. doi: 10.1136/jnnp-2014-307904. Epub 2014 Jul 8.

Supplemental Content

Support Center